Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

3

Genotypic resistance to entecavir in chronic hepatitis B patients

Byeong Uk Kim, M.D., Ja Chung Goo, M.D., Byeong Chul Park, M.D., Soo Ok Kim, Ph.D. Sun Pyo Hong, Ph.D. Jee In Jeong, M.D., Hee Bok Chae, M.D., Seon Mee Park, M.D., Sei Jin Youn, M.D.

Clin Mol Hepatol. 2010;16(2):147-157. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.147

View: 5105 Download: 24 Crossref: 2

Clinical Outcomes of Lamivudine Therapy in HBeAg Positive Chronic Hepatitis B with Minimally Elevated ALT

Dong Ha Han , Neung Hwa Park , Jung Woo Shin , Seok Won Jung , Young Tae Hwang , Hyun Soo Kim , In Du Jeong , Sung Jo Bang , Do Ha Kim

Clin Mol Hepatol. 2007;13(2):146-156. Published online January 1, 1970

View: 2714 Download: 20

Comparison of Clinical Outcome Between Patients Continuing and Discontinuing Lamivudine Therapy in Acute Exacerbation After Viral breakthrough During Lamivudine Therapy in Chronic Hepatitis B

Jong Ryul Eun

Clin Mol Hepatol. 2006;12(2):184-190. Published online January 1, 1970

View: 2093 Download: 14

Correlation of HBV DNA Level and Viral Breakthrough During Lamivudine Therapy for Chronic Hepatitis B

Hee Seung Park , Dong Hyun Lee , Jeong Heo , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song , Mong Cho

Clin Mol Hepatol. 2006;12(2):173-183. Published online January 1, 1970

View: 2710 Download: 22

The Clinical Meaning of the Emergence of Viral Breakthrough during Lamivudine Treatment in Patients with Hepatitis B Virus Related Chronic Liver Disease

Chan Bog Park , Hyun Jeung Lim , Byung Cheol Yun , Sang Uk Lee , Byung Hoon Han

Clin Mol Hepatol. 2004;10(2):108-116. Published online January 1, 1970

View: 2540 Download: 18

Predictive Factors and Clinical Outcome of Viral Breakthrough during Lamivudine Treatment for Chronic Hepatitis B Infection

Park Neunghwa , Sin Jeongu , Park Jongho , Bang Seongjo , Kim Daehyeon , Ju Gwanglo , Kim Doha

Clin Mol Hepatol. 2003;9(4):293-303. Published online January 1, 1970

View: 2267 Download: 12

Efficacy of Lamivudine in Patients with Hepatitis B e Antigen-Negative Chronic Liver Diseases

In Du Jeong , Neung Hwa Park , Byung Chul Kim , Jee Hyun Park , Kwang Won Seo , Dae Hyun Kim , Kwang Ro Joo , Do Ha Kim

Clin Mol Hepatol. 2003;9(2):69-78. Published online January 1, 1970

View: 2701 Download: 11

Clinical and Virologic Characteristics of Lamivudine Resistance in HBV-associated Chronic Liver Disease

Sun Suk Kim, M.D., Moon Gi Chung, M.D., Ki Tak Ju, M.D., Dong Kyun Park, M.D. Oh Sang Kwon, M.D.,Yang Suh Koo, M.D., Yu Kyung Kim, M.D., Duck Ju Choi, M.D. Yu Jin Hwang, Ph.D.* and Ju Hyun Kim, M.D.

Clin Mol Hepatol. 2002;8(4):405-417. Published online January 1, 1970

View: 2216 Download: 15

Viral Breakthrough in HbeAg-Negative Chronic Hepatitis B Patients Receiving Lamivudine Therapy

Yun Jung Chang, M.D., Jeong Yoon Yim, M.D., Nam Young Cho, M.D., Chang Won Choi, M.D., Soo Jung Baek, M.D., Soo Hyun Ahn, M.D., Do Won Choi, M.D., Yong Dae Kwon, M.D., Sun Suk Kim, M.D.**, Oh Sang Kwon, M.D.**, Ju Hyun Kim, M.D.**, Jong Eun Yeon, M.D., Jin Won Song, M.D.*, Kwan Soo Byun, M.D. and Chang Hong Lee, M.D.

Clin Mol Hepatol. 2002;8(4):397-404. Published online January 1, 1970

View: 2510 Download: 18

Clinical Outcome in Cases of Viral Breakthrough During Lamivudine Therapy in Chronic Hepatitis B Patients

Soo Hyun Ahn, M.D., Yun Jung Chang, M.D., Seong Nam Oh, M.D., Do Won Choi, M.D., Soo Jung Baek, M.D., Won Seok Jeong, M.D., Chang Won Choi, M.D., Kyoung Oh Kim, M.D., Hyung Joon Yim, M.D., Nam Young Jo, M.D., Jong Jae Bak, M.D., Jae Seon Kim, M.D., Young-Tae Bak, M.D., Myung Seok Lee, M.D.*, Jong Eun Yeon M.D., Kwan Soo Byun, M.D. and Chang Hong Lee, M.D.

Clin Mol Hepatol. 2002;8(4):389-396. Published online January 1, 1970

View: 2273 Download: 17

Efficacy of 1 - Year Lamivudine Treatment in the Patient of Chronic B Hepatitis and Liver Cirrhosis

Yong Song Kim,Seung Soo Kim,Hung Yong Jin,Myung Sin Ma,Seung Ok Lee,Soo Teik Lee,Dae Ghon Kim,Deuk Soo Ahn

Clin Mol Hepatol. 2001;7(2):171-180. Published online January 1, 2000

View: 2134 Download: 12

The Effect of Lamivudine in Chronic Liver Disease associated with Hepatitis B Virus

Kwang Hee Kim, M.D., Soon Ho Um, M.D., Ho Sang Ryu, Jae Won Lee* , Young Sun Kim, M.D., Yoon hong Kim, M.D., Jung Whan Lee, M.D., Chang Don Kang, M.D., Byung Won Hur, Yoon Tae Jin, Hoon Jai Chun, Chi Wook Song, M.D., Sang Woo Lee, M.D., Jai Hyun Choi, M.D., Chang Duck Kim, M.D., Jin Hai Hyun, M.D.

Clin Mol Hepatol. 2000;6(2):172-186. Published online January 1, 2000

View: 2209 Download: 23

The Effect of Long-term Lamivudine Therapy for Chronic Liver Disease due to Hepatitis B Virus

Kwang Hyub Han, M.D., Jin Suk Kim, M.D., Hyo Young Chung Sang Hoon Ahn, M.D., Yong Han Paik, M.D., Kwan Sik Lee, M.D., Chae Yoon Chon, M.D. and Young Myoung Moon, M.D.

Clin Mol Hepatol. 1999;5(2):97-104. Published online January 1, 2000

View: 2368 Download: 14

1 |

Viewed By 5366	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5330	MAFLD: How is it different from NAFLD?
Viewed By 5213	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3895	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3859	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search